The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2019 Aug 28

PMID 31450914

Citations 6

Authors

Sasidharanpillai Sabeena

Santhosh Kuriakose

Damodaran Binesh

Jazeel Abdulmajeed

Giselle DSouza

Amrutha Ramachandran

Bindu Vijaykumar

Sushama Aswathyraj

Santhosha Devadiga

Nagaraja Ravishankar

Govindakarnavar Arunkumar

Affiliations

Soon will be listed here.

Abstract

Background: WHO has recommended Visual Inspection with Acetic acid (VIA) or Human Papillomavirus (HPV) DNA testing if feasible, for cervical cancer screening in low income countries. However, the number of women undergoing screening is very low as a result of limited information, inadequate infrastructure and invasive nature of sampling. Methods: A cross sectional study was carried out comparing HPV DNA detection by Polymerase Chain Reaction (PCR) in paired cervical and urine samples procured from histologically confirmed cervical cancer cases. Results: Amongst the samples collected from 114 cervical cancer cases, HPV DNA was tested positive in cervical samples of 89 (78.1%) and urine samples of 55 (48.2%) patients. The agreement between the two sampling methods was 66.7% and the kappa value was 0.35 indicating a fair agreement. The sensitivity of HPV detection using urine samples was 59.6% (95% confidence interval 49.16%-69.15%) and the specificity was 92% (95% confidence interval 75.0%-97.8%). Conclusion: Even though not acceptable as an HPV DNA screening tool due to low sensitivity, the urine sampling method is inexpensive and more socially acceptable for large epidemiological surveys in developing countries to estimate the burden.

Citing Articles

Non-invasive early-stage cancer detection: current methods and future perspectives.

Chacko N, Ankri R Clin Exp Med. 2024; 25(1):17.

PMID: 39708168 PMC: 11663200. DOI: 10.1007/s10238-024-01513-x.

Evaluating different samples & techniques for hr-HPV DNA genotyping to improve the efficiency of risk profiling for oral & cervical cancers in Sikkim, India.

Gupta C, Sherpa M, Lucksom P, Pradhan A, Chettri M Indian J Med Res. 2024; 160(2):226-235.

PMID: 39513209 PMC: 11544568. DOI: 10.25259/ijmr_877_23.

A Novel Urine Test Biosensor Platform for Early Lung Cancer Detection.

Wiesel O, Sung S, Katz A, Leibowitz R, Bar J, Kamer I Biosensors (Basel). 2023; 13(6).

PMID: 37366992 PMC: 10296167. DOI: 10.3390/bios13060627.

Cancer Screening Recommendations During the COVID-19 Pandemic: Scoping Review.

Shah S, McElfish P JMIR Cancer. 2022; 8(1):e34392.

PMID: 35142621 PMC: 8914792. DOI: 10.2196/34392.

Advances in HPV Screening Tests for Cervical Cancer-A Review.

Lucksom P, Sherpa M, Pradhan A, Lal S, Gupta C J Obstet Gynaecol India. 2022; 72(1):13-18.

PMID: 35125734 PMC: 8804131. DOI: 10.1007/s13224-021-01569-9.

References

Stanczuk G, Kay P, Allan B, Chirara M, Tswana S, Bergstrom S . Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer. J Med Virol. 2003; 71(1):110-4. DOI: 10.1002/jmv.10456. View

Munoz M, Camargo M, Soto-De Leon S, Sanchez R, Pineda-Pena A, Perez-Prados A . Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women. J Clin Microbiol. 2013; 51(11):3688-93. PMC: 3889752. DOI: 10.1128/JCM.01302-13. View

Piyathilake C, Badiga S, Chambers M, Brill I, Matthews R, Partridge E . Accuracy of urinary human papillomavirus testing for the presence of cervical human papillomaviruses and higher grades of cervical intraepithelial neoplasia. Cancer. 2016; 122(18):2836-44. PMC: 5014670. DOI: 10.1002/cncr.30123. View

Hagihara M, Yamagishi Y, Izumi K, Miyazaki N, Suzuki T, Kato H . Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus. J Infect Chemother. 2016; 22(8):559-62. DOI: 10.1016/j.jiac.2016.05.009. View

Tanzi E, Bianchi S, Fasolo M, Frati E, Mazza F, Martinelli M . High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping. J Med Virol. 2012; 85(1):91-8. DOI: 10.1002/jmv.23434. View

Nygard J, Skare G, Thoresen S . The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen. 2002; 9(2):86-91. DOI: 10.1136/jms.9.2.86. View

Mendez K, Romaguera J, Ortiz A, Lopez M, Steinau M, Unger E . Urine-based human papillomavirus DNA testing as a screening tool for cervical cancer in high-risk women. Int J Gynaecol Obstet. 2013; 124(2):151-5. PMC: 4010249. DOI: 10.1016/j.ijgo.2013.07.036. View

Bobdey S, Sathwara J, Jain A, Balasubramaniam G . Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol. 2017; 37(4):278-285. PMC: 5234166. DOI: 10.4103/0971-5851.195751. View

Sasieni P, Castanon A, Cuzick J . Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ. 2009; 339:b2968. PMC: 2718082. DOI: 10.1136/bmj.b2968. View

10.

Nilyanimit P, Chansaenroj J, Karalak A, Laowahutanont P, Junyangdikul P, Poovorawan Y . Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay. PeerJ. 2017; 5:e3910. PMC: 5637711. DOI: 10.7717/peerj.3910. View

11.

Gravitt P, Peyton C, Alessi T, Wheeler C, Coutlee F, Hildesheim A . Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000; 38(1):357-61. PMC: 88724. DOI: 10.1128/JCM.38.1.357-361.2000. View

12.

Schmitz M, Scheungraber C, Herrmann J, Teller K, Gajda M, Runnebaum I . Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. J Clin Virol. 2009; 44(4):302-7. DOI: 10.1016/j.jcv.2009.01.006. View

13.

Bernal S, Palomares J, Artura A, Parra M, Cabezas J, Robles A . Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test. J Clin Virol. 2014; 61(4):548-52. DOI: 10.1016/j.jcv.2014.10.001. View

14.

Cuschieri K, Nandwani R, McGough P, Cook F, Hogg L, Robertson C . Urine testing as a surveillance tool to monitor the impact of HPV immunization programs. J Med Virol. 2011; 83(11):1983-7. DOI: 10.1002/jmv.22183. View

15.

Khan G, Kangro H, Coates P, Heath R . Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. J Clin Pathol. 1991; 44(5):360-5. PMC: 496862. DOI: 10.1136/jcp.44.5.360. View

16.

Bhatla N, Aoki D, Sharma D, Sankaranarayanan R . Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018; 143 Suppl 2:22-36. DOI: 10.1002/ijgo.12611. View

17.

Nilyanimit P, Wanlapakorn N, Niruthisard S, Pohthipornthawat N, Karalak A, Laowahutanont P . Detection of human papillomavirus in male and female urine by electrochemical DNA chip and PCR sequencing. Asian Pac J Cancer Prev. 2013; 14(9):5519-25. DOI: 10.7314/apjcp.2013.14.9.5519. View

18.

Sahasrabuddhe V, Gravitt P, Dunn S, Brown D, Allen R, Eby Y . Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol. 2013; 52(1):187-92. PMC: 3911475. DOI: 10.1128/JCM.01623-13. View

19.

Khunamornpong S, Settakorn J, Sukpan K, Lekawanvijit S, Katruang N, Siriaunkgul S . Comparison of Human Papillomavirus Detection in Urine and Cervical Samples Using High-Risk HPV DNA Testing in Northern Thailand. Obstet Gynecol Int. 2017; 2016:6801491. PMC: 5215104. DOI: 10.1155/2016/6801491. View

20.

Sabeena S, Bhat P, Kamath V, Mathew M, Aswathyraj S, Devadiga S . Detection of Genital HPV Infection Using Urine Samples: a Population Based Study in India. Asian Pac J Cancer Prev. 2016; 17(3):1083-8. DOI: 10.7314/apjcp.2016.17.3.1083. View